Protection of the Peyer's patch‐associated crypt and villus epithelium against methotrexate‐induced damage is based on its distinct regulation of proliferation
- 2 July 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 198 (1) , 60-68
- https://doi.org/10.1002/path.1183
Abstract
The crypt and villus epithelium associated with Peyer's patches (PPs) is largely spared from methotrexate (MTX)‐induced damage, compared with the non‐patch (NP) epithelium. To assess the mechanism(s) preventing damage to the PP epithelium after MTX treatment, epithelial proliferation, apoptosis, and cell functions were studied in a rat‐MTX model. Small intestinal segments containing PPs were excised after MTX treatment. Epithelial proliferation and apoptosis were assessed by detection of incorporated BrdU and cleaved caspase‐3, respectively. Epithelial functions were determined by the expression of cell type‐specific gene products at mRNA and protein level. Before and after MTX treatment, the number of BrdU‐positive cells was higher in PP crypts than in NP crypts. BrdU incorporation was diminished in NP crypts, while in PP crypts incorporation was hardly affected. In PP and NP crypts, similar and increased levels of cleaved caspase‐3‐positive cells were observed after MTX. The enterocyte markers, sucrase‐isomaltase, sodium‐glucose co‐transporter 1, glucose transporters 2 and 5, and intestinal and liver fatty acid binding protein, were down‐regulated after MTX in NP epithelium but not in PP epithelium. In contrast, expression of the goblet cell markers, Muc2 and trefoil factor 3, and the Paneth cell marker, lysozyme, was maintained after MTX in both PP and NP epithelium. In conclusion, as MTX‐induced apoptosis was similar in PP and NP crypts, the protection of the PP epithelium seems to be based on differences in the regulation of epithelial proliferation. Enterocyte function in the PP epithelium was unaffected by MTX treatment. Goblet and Paneth cell function was maintained in both NP and PP epithelium. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
Funding Information
- Numico BV, Zoetermeer, The Netherlands
This publication has 25 references indexed in Scilit:
- The small intestinal epithelium near Peyer's patches is protected against damage induced by the cytostatic drug methotrexateGastroenterology, 2000
- Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.Journal of Clinical Investigation, 1994
- Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium.The Journal of cell biology, 1992
- Regulation of sucrase-isomaltase gene expression along the crypt-villus axis of rat small intestineBiochemical and Biophysical Research Communications, 1990
- Radiobiology and Stathmokinetics of Intestinal Crypts Associated with Patches of PeyerInternational Journal of Radiation Biology, 1987
- Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probesDevelopmental Biology, 1984
- Topographic variations in the clonogenic response of intestinal crypts to cytotoxic treatmentsThe British Journal of Radiology, 1983
- Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.Journal of Clinical Pathology, 1982
- Light and scanning electron microscopic observations of the effects of sublethal doses of methotrexate on the rat small intestineThe Anatomical Record, 1978
- Changes in the mucosa of the small intestine following methotrexate administration or abdominal X‐irradiationJournal of Anatomy, 1974